At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02359 WUXI APPTEC
Not Yet Opened 11-16 16:08:13
189.500
-2.100
-1.10%
High193.300
Low187.400
Vol4.47M
Open189.100
D1 Closing191.600
Amplitude3.08%
Mkt Cap571.34B
Tradable Cap102.52B
Total Shares3.02B
T/O847.70M
T/O Rate0.83%
Tradable Shares541.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Smart Finance A/H Share Premium Report for November 16
Hong Kong Stocks Midday Review: Hang Seng Falls 0.92%, Tech Index Down 1.41%, Internet and Gold Stocks Decline Broadly, Biopharma Stocks Buck the Trend
Hong Kong Stock Announcement Highlights: PEIPORT HOLD to Change Controlling Shareholder with About 26.75% Discount Full Takeover Offer, Trading Resumes November 10
WuXi AppTec Co Ltd is a China-based company principally engaged in the business of new drug research and development and manufacturing services. The Company conducts its business through six segments. The WuXi Chemistry Segment is primarily engaged in providing new drug research, development and manufacturing services. The WuXi Testing Segment is primarily engaged in providing pharmaceuticals, medical devices, and in vitro diagnostic reagents services. The WuXi Biology Segment is primarily engaged in providing drug discovery and research services. The WuXi ATU Segment is primarily engaged in providing customers with integrated medical product process development, manufacturing and testing services. The WuXi DDSU Segment is primarily engaged in providing customers with integrated new drug research and development services. The Other Segment is primarily engaged in administrative services, sales of raw materials and sales of waste materials.